Drug class in one race
Bruton's tyrosine kinase (BTK) drugs for Multiple Sclerosis
2 tracked Bruton's tyrosine kinase (BTK) drugs in the Multiple Sclerosis race. The class explanation lives on the Bruton's tyrosine kinase (BTK) page; the full indication pipeline across every mechanism is on the Multiple Sclerosis page.
1 Phase 31 Phase 2
Head-to-head evidence: BIIB091 vs Tolebrutinib